-
Did you mean
- diagnost gi
- diagnostics gi
-
Norovirus RT-PCR KitCatalog #: 86-NVIHU-100
Sensitivity: ≥ 50 RNA copies
Sample Types: Stool
Sample Size(s): 100 Tests
Detection: Fluorescence -
Norovirus I & II RT-PCR Kit
Catalog #: 86-NV2HU-100
Sensitivity: ≥ 50 RNA copies
Sample Types: Stool
Sample Size(s): 100 Tests
Detection: Fluorescence
Multiplex Biomarker Instrumentation
Discover Automated Multiplex Testing to Simplify Batch AnalysisALPCO has partnered with DYNEX® Technologies to leverage the DYNEX Multiplier® powered by SmartPlex® technology to fully automate multiplex analysis of novel protein biomarkers.DYNEX Multiplier® Automated Chemiluminescence AnalyzerThe DY...
AACC 2023
Skip the crowd and reserve your time for a demonstration or individual meeting with a member of our team.Stop by Booth #2547
Ask About Our Targeted Solutions for Your GI Testing.Customized solutions for your calprotectin testing needs.GI SOLUTIONSEnsure AccuracyNew! Calprotectin Immunoturbidimetric...
Clinical Research
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.ALPCO has been serving the needs of clinical researchers and clinical diagnostics labs for over 30 years, and we now offer a broad product menu of proprietary automated sample-to-answer platforms. We’re ...
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
GI Testing
Calprotectin Chemiluminescence ELISA (80-CALPHU-CH01)
The Calprotectin Chemiluminescence ELISA is an in vitro diagnostic chemiluminescent assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human sto...
AutoPlex Automated Multiplex Biomarker Analysis
ALPCO’s automated multiplex assay, AutoPlex GI Panel, provides sensitive and accurate measurement of up to 5 GI biomarkers in human stool samples. The panel combines the workflow advantages of multiplexing with the proven reliability of traditional chemiluminescence sandwich immunoassays to enable b...
Enhance Your Lab’s Molecular GI Portfolio
Molecular GI testing for bacteria such as salmonella, vibrio, and E. coli, and viral pathogens including norovirus and rotavirus, is instrumental in the diagnosis and treatment of infection and dysbiosis. In addition, many gastrointestinal disorders often require protein biomarker tests to aid in ac...
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
Diagnostic Testing in GI Health
60 to 70 million Americans are affected by gastrointestinal (GI) diseases and disorders each year. The estimated annual U.S. cost associated with GI disorders is over 140 billion dollars. Gl diseases and disorders can have a significant impact on quality of life, often contributing to anxiety ...
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
Stool-Based Biomarkers to Differentiate Between IBD and IBS
What are IBD and IBS?
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are two different gastrointestinal tract issues affecting millions of people every day. Although there is some overlap between symptoms of IBD and IBS, differences still remain in regards to pathologies, risks...
5 Reasons to Add GI Biomarker Testing to Your Lab’s Menu
Digestive Diseases Affect More than 70 Million Americans Each Year. The estimated annual cost of GI disorders is $135 billion, with patients reporting a higher incidence of depression and absenteeism. Comparatively, approximately 34 million Americans have diabetes.
ALPCO Announces the Commercial Launch of its FDA 510(k) Cleared Calprotectin Immunoturbidimetric Assay
Salem, NH, December 19, 2023 – American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, proudly announces the commercial launch of its FDA 510(k) cleared Calprotectin Immunoturbidimetric Assay, enhancing its suite of Gastrointestinal (GI) d...
Consolidate and Improve Calprotectin Testing on Clinical Chemistry Analyzers with ALPCO
For laboratories with a compatible clinical chemistry analyzer, upgrading to the calprotectin immunoturbidimetric assay can improve efficiency and generate additional capacity. Laboratories can potentially eliminate a CLIA system or simply create new capacity on that system by transferring calprotec...
Classes of Biologics for the Treatment of IBD
Monoclonal antibody (mAb) biologics have been used to treat inflammatory bowel disease (IBD) for several years. Various classes of biologics for the treatment of IBD exist and include cytokine blockers and integrin blockers. Within these classes are mAbs that target different proinflammatory protein...
ALPCO to Exhibit at the 2021 AACC Annual Scientific Meeting and Clinical Lab Expo
We’re excited to announce that ALPCO will be exhibiting at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo at the Georgia World Congress Center in Atlanta, GA from September 28-30. We will be showcasing our growing menu of clinical test kits at booth 3431. Stop by to learn more about...
MacroArray Diagnostics GmbH (MADx) partners with ALPCO to offer a fully automated sample-to-answer multiplex allergy test solution to the North American market
FOR IMMEDIATE RELEASE
Salem, NH – February 1, 2022:
ALPCO (Salem, NH), a leading US producer of novel immunoassay testing platforms, recently announced an exclusive distribution partnership with MacroArray Diagnostics GmbH (Vienna, Austria). Together they offer a comprehensive line of testing ...
IBS Awareness Month: Facts About IBS
In support of IBS Awareness Month, we created this short video to share some important facts about IBS and spread the word about this incurable, debilitating disorder.
Be sure to like and share our video to show your support of IBS Awareness Month!
https://youtu.be/6K_55Bg922s
Quick Facts Abo...
High Throughput Calprotectin Testing with ALPCO Immunoturbidimetric Assay
Maximize lab efficiency with ALPCO's calprotectin immunoturbidimetric assay. Leverage existing analyzers, ensure accurate results, and improve turnaround times.
Boost Profitability with In-House Calprotectin Testing from ALPCO
Test results from outside laboratories can sometimes take up to 5 days. Random access testing enables laboratories to offer affordable same-day results. On-site testing eliminates the shipping process and maintains remnant samples on-site.
Researching Therapeutic Drug Monitoring for IBD
Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves the quality of life for patients. However, many challenges are associated with using biologics to treat IBD such as immunogenetic reactions and th...
Organ Crosstalk in Obesity and NAFLD
The liver is vital to various metabolic functions including lipid and glucose metabolism. In order to maintain homeostasis, efficient gut-liver and adipose tissue-liver communications are needed1,2. Research indicates that obesity induced dysfunctions within these crosstalks can lead to imbalances i...
Real-time PCR/RT-PCR Products for Gastrointestinal Pathogen Detection
Gastrointestinal (GI) pathogens consist of bacterial, viral, and parasitic groups. Bacterial, viral, and parasitic pathogens are caused by direct contact, indirect contact, and contaminated food and water. The most common pathogen is viral, which infects a host by introducing genetic material ...